Brainomix

Brainomix is a pioneering company based in the UK, dedicated to transforming the landscape of medical imaging and artificial intelligence. With a strong focus on stroke care, Brainomix develops innovative software solutions that enhance the diagnosis and treatment of patients suffering from acute strokes.

The company’s flagship product, e-CT, leverages advanced algorithms to analyse CT scans, providing clinicians with critical insights that facilitate timely decision-making. This technology not only improves patient outcomes but also streamlines the workflow within healthcare settings.

Brainomix is committed to research and development, continuously striving to integrate the latest advancements in AI and machine learning into their products. The team comprises experts in neurology, radiology, and engineering, all working collaboratively to push the boundaries of what is possible in medical imaging.

In addition to its core offerings, Brainomix actively engages in partnerships with healthcare providers and academic institutions to foster innovation and improve clinical practices. The company’s vision is to empower healthcare professionals with tools that enhance diagnostic accuracy and patient care.

With a growing presence in the global market, Brainomix aims to expand its reach and impact, ensuring that cutting-edge technology is accessible to healthcare systems worldwide. The company’s dedication to quality and excellence has earned it recognition and accolades within the industry.

As Brainomix continues to evolve, it remains steadfast in its mission to revolutionise stroke management and contribute to the advancement of medical technology.